Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More News and Success Stories.
-
09 Oct 2026
See more Catalonia to gain new advanced robotics and physical AI hub with ABB RoboticsCatalonia to gain new advanced robotics and physical AI hub with ABB Robotics
-
05 Oct 2026
See more Clio makes a long-term bet on Barcelona to develop the AI behind its legal platformClio makes a long-term bet on Barcelona to develop the AI behind its legal platform
-
02 Oct 2026
See more Mondelēz has invested €27 million in its Catalan production sites since 2020, supporting 1,400 jobsMondelēz has invested €27 million in its Catalan production sites since 2020, supporting 1,400 jobs
-
28 Sep 2026
See more Anaconda Biomed secures €49 million for its stroke technology produced near BarcelonaAnaconda Biomed secures €49 million for its stroke technology produced near Barcelona
